StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines other Marketed & Partnered Products — Net Product Revenue ($M) ($M)

Form 10-Q / 10-K Segment Disaggregation Note (XBRL)

Latest, FY2025
83.7
Period ended Dec 31, 2025
Change on a year earlier
-12.9%
96.1 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Marketed & Partnered Products — Net Product Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 202583.7-12.9%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202496.1-19.4%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 2023119+225.1%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202236.7+376.6%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 20217.70+3,750.0%Form 10-K (filed 2024-02-26) ↗
FY2020Dec 31, 20200.20–Form 10-K (filed 2023-02-27) ↗
FY2019Dec 31, 20190–Form 10-K (filed 2022-02-28) ↗
FY2018Dec 31, 20180–Form 10-K (filed 2021-02-25) ↗

Breakdown

What makes up other marketed & partnered products — net product revenue ($m)

Cite this data

StockData. (2026). BeOne Medicines Other Marketed & Partnered Products — Net Product Revenue ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/prod_other_tot

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.